TY  - JOUR
AU  - Jimenez-Guerrero, Rocio
AU  - Gasca, Jessica
AU  - Flores, M Luz
AU  - Perez-Valderrama, Begoña
AU  - Tejera-Parrado, Cristina
AU  - Medina, Rafael
AU  - Tortolero, Maria
AU  - Romero, Francisco
AU  - Japon, Miguel A
AU  - Saez, Carmen
PY  - 2018
DO  - 10.3390/cancers10120490
SN  - 2072-6694
UR  - http://hdl.handle.net/10668/13326
T2  - Cancers
AB  - Paclitaxel is a treatment option for advanced or metastatic bladder cancer after the failure of first-line cisplatin and gemcitabine, although resistance limits its clinical benefits. Mcl-1 is an anti-apoptotic protein that promotes resistance to...
LA  - en
PB  - MDPI AG
KW  - apoptosis
KW  - autophagy
KW  - bladder cancer
KW  - obatoclax
KW  - paclitaxel
KW  - Gemcitabine
KW  - Cisplatin
KW  - Beclin-1
KW  - Caspases
KW  - Apoptosis Regulatory Proteins
KW  - Paclitaxel
KW  - Urinary Bladder Neoplasms
KW  - Autophagy
KW  - Blotting, Western
KW  - Carcinoma
TI  - Obatoclax and Paclitaxel Synergistically Induce Apoptosis and Overcome Paclitaxel Resistance in Urothelial Cancer Cells.
TY  - research article
VL  - 10
ER  -